Pharmocotherapy Principles and Practice-Urinary Incontinence and Pediatric Enuresis

Contact Hours: 2.0

ACPE No: 014-999-07-065-H04

Activity Type:

Release Date:
Expiration Date:

Learning Objectives

Upon completion of this activity the participant should be able to:
Upon completion of the chapter, the reader will be able to
1. Explain the pathophysiology of the major types of urinary incontinence (urge, stress, overflow, and functional) and pediatric enuresis.
2. Recognize the signs and symptoms of the major types of urinary incontinence and pediatric enuresis in individual patients.
3. List the treatment goals for a patient with urinary incontinence or pediatric enuresis.
4. Compare and contrast anticholinergic/antispasmodics, -adrenoceptor agonists, dual serotonin-norepinephrine reuptake inhibitors, vaginal estrogens, cholinomimetics, tricyclic antidepressants, and vasopressin analogues in terms of mechanism of action, treatment outcomes, adverse effects, and drug-drug interaction potential when used to manage urinary incontinence or pediatric enuresis.
5. Identify factors that guide drug selection for an individual patient.
6. Formulate a monitoring plan for a patient on a given treatment regimen based on patient-specific information.
7. Describe indicators for combination drug therapy of urinary incontinence or pediatric enuresis.
8. Describe nonpharmacologic treatment approaches (including surgery) for urinary incontinence or pediatric enuresis.
9. Formulate appropriate patient counseling information for patients undergoing drug therapy for urinary incontinence or pediatric enuresis.

Faculty:

Computer Requirements for Online Courses
PC


MAC

Acpelogo The University of Georgia College of Pharmacy is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.